1. Home
  2. CTMX vs AE Comparison

CTMX vs AE Comparison

Compare CTMX & AE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • AE
  • Stock Information
  • Founded
  • CTMX 2008
  • AE 1947
  • Country
  • CTMX United States
  • AE United States
  • Employees
  • CTMX N/A
  • AE N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • AE Oil Refining/Marketing
  • Sector
  • CTMX Health Care
  • AE Energy
  • Exchange
  • CTMX Nasdaq
  • AE Nasdaq
  • Market Cap
  • CTMX 89.1M
  • AE 95.2M
  • IPO Year
  • CTMX 2015
  • AE N/A
  • Fundamental
  • Price
  • CTMX $0.89
  • AE $37.20
  • Analyst Decision
  • CTMX Buy
  • AE Hold
  • Analyst Count
  • CTMX 6
  • AE 1
  • Target Price
  • CTMX $5.77
  • AE $38.00
  • AVG Volume (30 Days)
  • CTMX 1.1M
  • AE 25.7K
  • Earning Date
  • CTMX 11-07-2024
  • AE 11-12-2024
  • Dividend Yield
  • CTMX N/A
  • AE 2.58%
  • EPS Growth
  • CTMX N/A
  • AE N/A
  • EPS
  • CTMX 0.16
  • AE N/A
  • Revenue
  • CTMX $126,617,000.00
  • AE $2,784,457,000.00
  • Revenue This Year
  • CTMX $11.79
  • AE $1.59
  • Revenue Next Year
  • CTMX N/A
  • AE $1.36
  • P/E Ratio
  • CTMX $5.51
  • AE N/A
  • Revenue Growth
  • CTMX 33.66
  • AE 0.04
  • 52 Week Low
  • CTMX $0.83
  • AE $22.30
  • 52 Week High
  • CTMX $5.85
  • AE $37.90
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 35.66
  • AE 82.20
  • Support Level
  • CTMX $0.84
  • AE $27.32
  • Resistance Level
  • CTMX $1.08
  • AE $37.90
  • Average True Range (ATR)
  • CTMX 0.07
  • AE 0.32
  • MACD
  • CTMX -0.01
  • AE 0.55
  • Stochastic Oscillator
  • CTMX 17.43
  • AE 93.48

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About AE Adams Resources & Energy Inc.

Adams Resources & Energy Inc is engaged in the business of crude oil marketing, tank truck transportation of liquid chemicals and dry bulk, and oil and gas exploration and production. The company operates through four business segments: Crude oil marketing segment offers crude oil marketing, and generates major revenue; Transportation segment includes tank truck transportation of liquid chemicals, pressurized gases, asphalt, and dry bulk; Pipeline and storage segment includes pipeline transportation, terminalling, and storage of crude oil; and Logistics and repurposing segment offers interstate bulk transportation logistics of crude oil, condensate, fuels, oils and other petroleum products and recycling and repurposing of off-specification fuels, lubricants, crude oil, and other chemicals.

Share on Social Networks: